Headquartered in Australia since 1996 and operating in the Asia Pacific region, Novotech is internationally recognized in the industry as a leading regional full-service CRO.
The Asia-Pacific CRO
Contact us to discuss your clinical trial needs.
Novotech is one of the Asia-Pacific’s leading clinical trial companies, and we have been for nearly two decades. Our streamlined and integrated clinical trial services are delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development.
Novotech’s registration clinical trials services are designed specifically for sponsors without local presence in the countries in which we operate. In particular the depth of our regulatory expertise across the region adds clarity and transparency to the trial startup process.
Our customized service means all facets of a trial are covered by the one contract, including third party vendor management and local site agreements, making working with us a simple and streamlined process.
Winner Asia Pacific Biotech CRO Company of The Year award in Frost & Sullivan’s 2017 Best Practice Awards.
“Over the past 20 years, Novotech has grown to become the leading contract research organisation (CRO) in Asia Pacific. Novotech has been very focussed on serving the biotech sector, which has allowed it to develop a unique niche in the global industry” said Frost & Sullivan Transformational Health Associate Director Ms Geeta Dhanoa, “Novotech, has succeeded across a diverse range of markets by having strong local leaders and tailoring its approach to address each country’s unique clinical trial conditions. Novotech’s flexible, customer-centric approach ensures its clients receive the best value from their investment; positioning the company for sustained growth in the region.”
Novotech (Australia) Pty Limited
Level 3, 235 Pyrmont Street
Telephone: +61 (0)2 8569 1400